Romanian Journal of Pediatrics Logo
  • Home
  • Aims & Scope
  • Standards
    • Editorial policies
    • Instructions for authors
    • Peer review process
    • Guidelines for Reviewers
    • Ethics and Malpractice policies
    • Official Journal’s protocols & statements
    • Open Access
    • Fees
  • Editorial Council
  • Peer Review Council
  • EMC | CME
  • How to
  • SUBSCRIBE
  • Menu

Arhiva autor

  • About
  • Latest Posts

Cristian Gheonea

Latest posts by Cristian Gheonea (see all)

  • PROVOCARI DE DIAGNOSTIC IN PNEUMONIA PEDIATRICA - 24/02/2017
  • CHALLENGES IN THE DIAGNOSIS OF PEDIATRIC PNEUMONIA - 24/02/2017
  • SINDROMUL STEVENS-JOHNSON (SSJ) SI NECROLIZA TOXICA EPIDERMALA DE ETIOLOGIE MEDICAMENTOASA - 22/02/2017

Articole semnate de acelasi autor in Revista Romana de Pediatrie:

PROVOCARI DE DIAGNOSTIC IN PNEUMONIA PEDIATRICA

SELECT ISSUE

Revista Romana de PEDIATRIE | Volumul LXV, Nr. 4, An 2016
ISSN 1454-0398  |  e-ISSN 2069-6175
ISSN-L 1454-0398
DOI: 10.37897/RJP

Indexed

DOI - Crossref
Similarity Check by iThenticate, worldwide No 1 professional plagiarism checking system
DOAJ
Scopus
NLM Catalog
Ebsco Host - Medline
Google Academic
Semantic Scholar

HIGHLIGHTS

National Awards “Science and Research”

NEW! RJP has announced the annually National Award for "Science and Research" for the best scientific articles published throughout the year in the official journal.

ICMJE- Recommendations

Read the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals.

Promoting Global Health

The published medical research literature is a global public good. Medical journal editors have a social responsibility to promote global health by publishing, whenever possible, research that furthers health worldwide.

PROVOCARI DE DIAGNOSTIC IN PNEUMONIA PEDIATRICA

Ligia Georgeta Stanescu, Catalina Bica, Cristian Gheonea, Radu Diaconu, Ramona Nedelcuta, Liliana Anghelina, Loredana Selaru and Andreea Pistolea

REZUMAT

Pneumonia este o formă de infecţie respiratorie acută care afectează plămânii şi care este cauza principală de mortalitate în rândul copiilor la nivel mondial. Pneumonia poate apărea la orice vârstă, dar este mai frecventă la copiii mici. Etiologia ei este adesea dificil de determinat, criteriile de diagnostic fiind adesea prezumptive şi bazându-se pe date epidemiologice, clinice, de laborator şi radiologice. Autorii prezintă trei cazuri de pneumonie diagnosticate la vârste diferite, subliniind particularităţile clinice, imagistice şi evolutive.

Cuvinte cheie: pneumonie, copii, vârstă, evoluţie

Full text | PDF

Ligia Georgeta Stanescu

CHALLENGES IN THE DIAGNOSIS OF PEDIATRIC PNEUMONIA

SELECT ISSUE

Revista Romana de PEDIATRIE | Volumul LXV, Nr. 4, An 2016
ISSN 1454-0398  |  e-ISSN 2069-6175
ISSN-L 1454-0398
DOI: 10.37897/RJP

Indexed

DOI - Crossref
Similarity Check by iThenticate, worldwide No 1 professional plagiarism checking system
DOAJ
Scopus
NLM Catalog
Ebsco Host - Medline
Google Academic
Semantic Scholar

HIGHLIGHTS

National Awards “Science and Research”

NEW! RJP has announced the annually National Award for "Science and Research" for the best scientific articles published throughout the year in the official journal.

ICMJE- Recommendations

Read the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals.

Promoting Global Health

The published medical research literature is a global public good. Medical journal editors have a social responsibility to promote global health by publishing, whenever possible, research that furthers health worldwide.

CHALLENGES IN THE DIAGNOSIS OF PEDIATRIC PNEUMONIA

Ligia Georgeta Stanescu, Catalina Bica, Cristian Gheonea, Radu Diaconu, Ramona Nedelcuta, Liliana Anghelina, Loredana Selaru and Andreea Pistolea

ABSTRACT

Pneumonia is a form of acute respiratory infection that affects the lungs and it is the leading cause of illness and death in children worldwide. Pneumonia can occur at any age, but it is more common in younger children. The etiology of pneumonia is often difficult to identify and the diagnostic criteria is based on corroborating epidemiological, clinical, laboratory and radiologic investigations. The authors present three cases diagnosed with pneumonia at different ages, underlying the clinical, imagistic and evolutive particularities.

Keywords: pneumonia, children, age, outcome

Full text | PDF

Ligia Georgeta Stanescu

SINDROMUL STEVENS-JOHNSON (SSJ) SI NECROLIZA TOXICA EPIDERMALA DE ETIOLOGIE MEDICAMENTOASA

SELECT ISSUE

Revista Romana de PEDIATRIE | Volumul LXV, Nr. 4, An 2016
ISSN 1454-0398  |  e-ISSN 2069-6175
ISSN-L 1454-0398
DOI: 10.37897/RJP

Indexed

DOI - Crossref
Similarity Check by iThenticate, worldwide No 1 professional plagiarism checking system
DOAJ
Scopus
NLM Catalog
Ebsco Host - Medline
Google Academic
Semantic Scholar

HIGHLIGHTS

National Awards “Science and Research”

NEW! RJP has announced the annually National Award for "Science and Research" for the best scientific articles published throughout the year in the official journal.

ICMJE- Recommendations

Read the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals.

Promoting Global Health

The published medical research literature is a global public good. Medical journal editors have a social responsibility to promote global health by publishing, whenever possible, research that furthers health worldwide.

SINDROMUL STEVENS-JOHNSON (SSJ) SI NECROLIZA TOXICA EPIDERMALA DE ETIOLOGIE MEDICAMENTOASA

Dalia Dop, Desdemona Stepan, Cristian Gheonea and Elena Carmen Niculescu

REZUMAT

Sindromul Stevens-Johnson (SSJ) şi necroliza toxică epidermală (NTE) sunt afecţiuni rare care apar după administrarea medicamentelor cu risc. Ambele reprezintă grade de severitate ale aceleiaşi afecţiuni şi sunt considerate urgenţe medicale, deoarece sunt potenţial letale. Sunt caracterizate prin sensibilitate cutaneomucoasă, eritem, necroză şi dezlipire buloasă similar arsurilor extinse. În continuare vă prezentăm 3 cazuri de SSJ/NTE a căror etiologie a fost, probabil, medicamentoasă (Paracetamol, Atomoxetinum, Sulfamethoxazolum + trimethoprinum), cu refacere totală după administrarea de imunoglobuline intravenos.

Cuvinte cheie: sindromul Stevens-Johnson, necroliza toxică epidermală, etiologie medicamentoasă, imunoglobuline intravenos

Full text | PDF

Dalia Dop

DRUG-INDUCED STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS

SELECT ISSUE

Revista Romana de PEDIATRIE | Volumul LXV, Nr. 4, An 2016
ISSN 1454-0398  |  e-ISSN 2069-6175
ISSN-L 1454-0398
DOI: 10.37897/RJP

Indexed

DOI - Crossref
Similarity Check by iThenticate, worldwide No 1 professional plagiarism checking system
DOAJ
Scopus
NLM Catalog
Ebsco Host - Medline
Google Academic
Semantic Scholar

HIGHLIGHTS

National Awards “Science and Research”

NEW! RJP has announced the annually National Award for "Science and Research" for the best scientific articles published throughout the year in the official journal.

ICMJE- Recommendations

Read the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals.

Promoting Global Health

The published medical research literature is a global public good. Medical journal editors have a social responsibility to promote global health by publishing, whenever possible, research that furthers health worldwide.

DRUG-INDUCED STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS

Dalia Dop, Desdemona Stepan, Cristian Gheonea and Elena Carmen Niculescu

ABSTRACT

Steven-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare diseases that appear following the administration of risk drugs. Both are severity grades of the same condition and are considered medical emergencies, because they are potentially lethal. They are characterized by mucocutaneous tenderness, erythema, necrosis and bullous detachment similar to extended burns. We report 3 cases of SJS/TEN in which the etiology was probably drug-related (Paracetamol, Atomoxetinum, Sulfamethoxazolum + trimethoprinum), with restitutio ad integrum following the administration of intravenous immunoglobulins.

Keywords: Steven-Johnson syndrome, toxic epidermal necrolysis, drug-related etiology, intravenous immunoglobulins

Full text | PDF

Dalia Dop

ETICA PRESCRIERII OFF-LABEL A MEDICAMENTELOR LA COPII. DILEMA SILDENAFILULUI

SELECT ISSUE

Revista Romana de PEDIATRIE | Volumul LXIV, Nr. 2, An 2015
ISSN 1454-0398  |  e-ISSN 2069-6175
ISSN-L 1454-0398
DOI: 10.37897/RJP

Indexed

DOI - Crossref
Similarity Check by iThenticate, worldwide No 1 professional plagiarism checking system
DOAJ
Scopus
NLM Catalog
Ebsco Host - Medline
Google Academic
Semantic Scholar

HIGHLIGHTS

National Awards “Science and Research”

NEW! RJP has announced the annually National Award for "Science and Research" for the best scientific articles published throughout the year in the official journal.

ICMJE- Recommendations

Read the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals.

Promoting Global Health

The published medical research literature is a global public good. Medical journal editors have a social responsibility to promote global health by publishing, whenever possible, research that furthers health worldwide.

ETICA PRESCRIERII OFF-LABEL A MEDICAMENTELOR LA COPII. DILEMA SILDENAFILULUI

Laszlo-Zoltan Sztankovszky, Magdalena Iorga, Cristian Gheonea and Georgiana Russu

REZUMAT

Prescripţia „off-label“ reprezintă administrarea medicamentelor pe o cale neaprobată, într-o formulare sau doză neaprobată la copii, sau sub intervalul de vârstă indicat pe prospectul aprobat al produsului. Cu toate acestea, tratamentul cu indicaţii off-label este un fenomen larg răspândit în clinicile de pediatrie. Deoarece multe dintre medicamentele prescrise nu au fost testate în mod adecvat la copii, această populaţie de pacienţi rămâne vulnerabilă. Pe de o parte, folosirea indicaţiilor off-label la copii determină o mulţime de controverse, pe de altă parte, fără această posibilitate, unii pacienţi ar putea fi lipsiţi de şansa de a fi trataţi. Lucrarea prezintă amplitudinea fenomenului de prescriere a medicamentelor cu indicaţii off-label la copii, evaluată în studii ştiinţifice din SUA şi Europa. În multitudinea de medicamente prescrise off-label la copii se înscrie şi Sildenafil. Autorii îşi propun prezentarea situaţiei din România cu privire la medicamentul Sildenafil şi utilizarea acestuia în unităţile de cardiologie pediatrică.

Cuvinte cheie: etica, medicamente, copii, prescriere, off-label

Full text | PDF

Laszlo-Zoltan Sztankovszky

THE ETHICS OF PRESCRIBING OFF-LABEL DRUGS IN CHILDREN. THE DILEMMA OF SILDENAFIL

SELECT ISSUE

Revista Romana de PEDIATRIE | Volumul LXIV, Nr. 2, An 2015
ISSN 1454-0398  |  e-ISSN 2069-6175
ISSN-L 1454-0398
DOI: 10.37897/RJP

Indexed

DOI - Crossref
Similarity Check by iThenticate, worldwide No 1 professional plagiarism checking system
DOAJ
Scopus
NLM Catalog
Ebsco Host - Medline
Google Academic
Semantic Scholar

HIGHLIGHTS

National Awards “Science and Research”

NEW! RJP has announced the annually National Award for "Science and Research" for the best scientific articles published throughout the year in the official journal.

ICMJE- Recommendations

Read the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals.

Promoting Global Health

The published medical research literature is a global public good. Medical journal editors have a social responsibility to promote global health by publishing, whenever possible, research that furthers health worldwide.

THE ETHICS OF PRESCRIBING OFF-LABEL DRUGS IN CHILDREN. THE DILEMMA OF SILDENAFIL

Laszlo-Zoltan Sztankovszky, Magdalena Iorga, Cristian Gheonea and Georgiana Russu

ABSTRACT

The off-label prescription means that medicines are administered by an unlicensed route, in an unlicensed formulation or dosage or to a child below the stated age range. The use of drugs in an off-label or unlicensed manner to treat children is widespread. Because many prescribed treatments for children have not been adequately tested in children, this population of patients remains a vulnerable one. On the one hand, prescribing off-label use drugs in children determines a lot of controversies but, one the other hand, without this possibility, could be deprived of a chance to be treated. The paper presents the widespread phenomenon of off-label us drugs in children, reflecting in scientific studies in USA and Europe. An important focus is on Romanian statistic of Sildenafil prescription and on dilemmatic use of it in pediatric cardiology unit.

Keywords: ethics, drugs, children, prescribing, off-label

Full text | PDF

Laszlo-Zoltan Sztankovszky


SEARCH

STANDARDE

  • Instructions for authors
  • Peer review process

Submit article

Submit your article to the journal by using the form here:

Submit

Subscriptions

To receive the Ro Journal of PEDIATRICS click here:

SUBSCRIBE
Publicare-RRPedia
Abonare_RRPedia

Partners

Partners logo

plic-maileditor@rjp.com.ro

Subscribe to the Newsletter

Articles from the journal are licensed under a 
Creative Commons Attribution 4.0 International License

 Terms & Conditions

Open Access Statement

Publisher : AMALTEA Medical Publishing House

The intended audience of the site content is professionals from the medical and pharmaceutical community.
This site does not collect any personal data nor does it use cookies that might obtain such data from your browser. [ info ]
Agree
Contact

Submit ARTICLE
E-mail: editor@rjp.com.ro  |  Mobile: +4 0742.155.512, M-F 09.00-18.00 EET

SUBSCRIPTIONS
E-mail: info@amaltea.ro |  Mobile: +4 0742.155.511, M-F 09.00-18.00 EET